Page de couverture de S6:E2 – Best Practices for ATTR-CM Management

S6:E2 – Best Practices for ATTR-CM Management

S6:E2 – Best Practices for ATTR-CM Management

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

In this episode, our Faculty, Dr. Nitasha Sarswat and Dr. Michelle Kittleson, discuss how biomarkers come into play for the diagnosis of transthyretin amyloid cardiomyopathy, or ATTR-CM. They will also discuss the latest therapeutic landscape, what the latest trial data show, and what’s in the pipeline.

Visit https://suitehome.atpointofcare.com/library/2684.12/page/0?subdomain=amyloidosis to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

This podcast is powered by Pinecast.

Ce que les auditeurs disent de S6:E2 – Best Practices for ATTR-CM Management

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.